P19-36. Preclinical Study of CombiHIVvac Vaccine

Retrovirology - United Kingdom
doi 10.1186/1742-4690-6-s3-p356
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Tuberculosis Vaccine Development :The Development of a Novel (Preclinical) DNA Vaccine

Human Vaccines
2010English

Recent Progress in Preclinical HIV-1 Vaccine Research

2019English

Preclinical Studies on a New Vaccine Formulation of BK-SE36, a Malaria Vaccine Candidate

Juntendo Medical Journal
2015English

Covering All the Bases: Preclinical Development of an Effective Staphylococcus Aureus Vaccine

Frontiers in Immunology
AllergyImmunology
2014English

Preparation and Preclinical Evaluation of a Novel Liposomal Complete-Core Lipopolysaccharide Vaccine

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2000English

Preclinical Laboratory Evaluation of a BivalentStaphylococcus aureusSaccharide: Exotoxin a Protein Conjugate Vaccine

Human Vaccines
2006English

Preclinical Evaluation of a Novel Non-Invasive Epicutaneous Vaccine Against Respiratory Syncytial Virus

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Extended Preclinical Safety, Efficacy and Stability Testing of a Live-Attenuated Chikungunya Vaccine Candidate

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2015English

P19-55 LB. Effective Control of a Pathogenic SIVmac239 Challenge by a Novel Heterologous Mucosal Prime and Intramuscular Boost Vaccine Strategy

Retrovirology
VirologyInfectious Diseases
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy